Hajime Aoyanagi

Temporal changes in left ventricular ejection fraction and their prognostic impacts in patients with Stage B heart failure.

T. Shiroto, S. Miyata, H. Shimokawa, 2020, International Journal of Cardiology.

Comparable prognostic impact of BNP levels among HFpEF, Borderline HFpEF and HFrEF: a report from the CHART-2 Study

T. Shiroto, S. Miyata, H. Shimokawa, 2018, Heart and Vessels.

Prognostic impact of residual stenosis after percutaneous coronary intervention in patients with ischemic heart failure - A report from the CHART-2 study.

T. Shiroto, S. Miyata, H. Shimokawa, 2019, International journal of cardiology.

Prognostic impacts of dynamic cardiac structural changes in heart failure patients with preserved left ventricular ejection fraction

T. Shiroto, S. Miyata, H. Shimokawa, 2020, European journal of heart failure.

Elevated Serum Non-HDL (High-Density Lipoprotein) Cholesterol and Triglyceride Levels as Residual Risks for Myocardial Infarction Recurrence Under Statin Treatment

T. Shiroto, S. Miyata, H. Shimokawa, 2019, Arteriosclerosis, thrombosis, and vascular biology.

Clinical characteristics and prognostic factors in elderly patients with chronic heart failure -A report from the CHART-2 study-

T. Shiroto, S. Miyata, H. Shimokawa, 2020, International journal of cardiology. Heart & vasculature.

Risk of de-novo heart failure and competing risk in asymptomatic patients with structural heart diseases.

T. Shiroto, S. Miyata, H. Shimokawa, 2020, International journal of cardiology.

Gender differences in prognostic relevance of self-care behaviors on mortality and hospitalization in patients with heart failure - A report from the CHART-2 Study.

T. Shiroto, S. Miyata, H. Shimokawa, 2019, Journal of cardiology.

Prognostic impacts of serum uric acid levels in patients with chronic heart failure: insights from the CHART‐2 study

T. Shiroto, S. Miyata, H. Shimokawa, 2020, ESC heart failure.